| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,052 |
6,549 |
$287K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,147 |
2,010 |
$134K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,457 |
1,386 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
442 |
413 |
$13K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
328 |
311 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
346 |
320 |
$11K |
| 87428 |
|
104 |
102 |
$7K |
| 81003 |
|
392 |
373 |
$843.22 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
51 |
48 |
$739.50 |
| 81025 |
|
26 |
26 |
$67.08 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
12 |
$1.82 |